Allogene to Reveal ALPHA3 CAR-T Trial Data Soon
South San Francisco, California | April 10, 2026 Allogene Therapeutics has announced that it will present the interim futility...
AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
South San Francisco, California | April 10, 2026 Allogene Therapeutics has announced that it will present the interim futility...
SHANGHAI, China, April 10, 2026 Oricell Therapeutics Holdings Limited has successfully closed a $110 million pre-IPO financing round, marking...
WELLINGTON, New Zealand & KINGSTON, Canada, April 7, 2026 BioOra Limited and Octane Biotech Inc. announced a strategic Letter...
TORONTO, Canada; HAIFA, Israel; and POMPANO BEACH, Florida, April 7, 2026 NurExone Biologic Inc. announced that its U.S. subsidiary...
AURORA, Colo., April 2, 2026 The University of Colorado Anschutz Medical Campus Gates Institute announced it has received U.S....
CAMBRIDGE, Mass., April 2, 2026 AvenCell Therapeutics, Inc. has achieved a major regulatory milestone with both the U.S. FDA...
WALTHAM, Mass., USA — April 2, 2026 Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™...
February 25, 2026 – San Diego, California, USA Bionano Genomics highlighted major scientific advancements in Optical Genome Mapping (OGM)...
BOSTON, Feb. 23, 2026 — Haemonetics Corporation announced that the U.S. Food and Drug Administration granted 510(k) clearance for...
SAN JOSE, Calif., Feb. 23, 2026 — Anixa Biosciences announced that immunology leader Jose Conejo-Garcia, M.D., Ph.D., will keynote...
